Appointed Independent Non-Executive Director in October 2017 and in the role of Senior Independent Director from September 2022 to September 2024. Marc is Chair of the Compliance & Culture Committee and a member of the Audit and Nomination & Governance Committees.
Marc is a proven leader with an astute strategic vision, capable of building significant international healthcare businesses. He has with strong commercial healthcare expertise. Marc is responsible for ESG through his role as Chair of the Compliance & Culture Committee.
Current external appointments
None
Previous experience
Marc commenced his healthcare and technology career at McKinsey & Company where he progressed to senior partner and eventually a founding partner of McKinsey’s Business Technology Office.
In 2001, Marc joined McKesson Corporation and served as Executive Vice President and member of their Executive Committee. He delivered strategic objectives and led over 40 acquisitions and divestments over a 10-year period.
In late 2011, he headed McKesson Speciality Health, which operates over 130 cancer centres across the US and provides market intelligence, supply chain services, patient access to therapy, provider and patient engagement and clinical trial support. In 2014, he was appointed Chair of the European Management Board at Celesio AG. He retired in March 2017 once he had improved operations, set the strategy and recruited his successor.
Nationality
British/American
Text